Similar articles for PMID: 28789568

Year	Number of Results
2007	1
2009	3
2010	8
2011	11
2012	5
2013	19
2014	18
2015	33
2016	43
2017	37
2018	35
2019	22
2020	15
2021	17
2022	9
2024	0

1

Temporal Trends in the Use of Antiplatelet Therapy in Patients With Acute Coronary Syndromes.

Esteve-Pastor MA, Ruíz-Nodar JM, Orenes-Piñero E, Rivera-Caravaca JM, Quintana-Giner M, Véliz-Martínez A, Tello-Montoliu A, PerniasEscrig V, Sandín Rollán M, Vicente-Ibarra N, MacíasVillanego MJ, Candela Sánchez E, Carrillo Alemán L, Lozano T, Valdés M, Marín F. Esteve-Pastor MA, et al. J Cardiovasc Pharmacol Ther. 2018 Jan;23(1):57-65. doi: 10.1177/1074248417724869. Epub 2017 Aug 9. J Cardiovasc Pharmacol Ther. 2018. PMID: 28789568

2

Clopidogrel, prasugrel or ticagrelor in patients with acute coronary syndromes undergoing percutaneous coronary intervention.

Yudi MB, Clark DJ, Farouque O, Eccleston D, Andrianopoulos N, Duffy SJ, Brennan A, Lefkovits J, Ramchand J, Yip T, Oqueli E, Reid CM, Ajani AE; Melbourne Interventional Group. Yudi MB, et al. Intern Med J. 2016 May;46(5):559-65. doi: 10.1111/imj.13041. Intern Med J. 2016. PMID: 26909472

3

Real-world clopidogrel utilization in acute coronary syndromes: patients selection and outcomes in a single-center experience.

Castini D, Persampieri S, Cazzaniga S, Ferrante G, Centola M, Lucreziotti S, Salerno-Uriarte D, Sponzilli C, Carugo S. Castini D, et al. Ther Adv Cardiovasc Dis. 2017 Dec;11(12):323-331. doi: 10.1177/1753944717738911. Ther Adv Cardiovasc Dis. 2017. PMID: 29134853 Free PMC article.

4

Contemporary use of P2Y₁₂ inhibitors in patients with ST-segment elevation myocardial infarction referred to primary percutaneous coronary interventions in Poland: Data from ORPKI national registry.

Rakowski T, Siudak Z, Dziewierz A, Plens K, Kleczyński P, Dudek D. Rakowski T, et al. J Thromb Thrombolysis. 2018 Jan;45(1):151-157. doi: 10.1007/s11239-017-1579-9. J Thromb Thrombolysis. 2018. PMID: 29075924 Free PMC article.

5

Contemporary antiplatelet treatment in acute coronary syndrome patients undergoing percutaneous coronary intervention: 1-year outcomes from the GReek AntiPlatElet (GRAPE) Registry.

Alexopoulos D, Xanthopoulou I, Deftereos S, Hamilos M, Sitafidis G, Kanakakis I, Pentara I, Vavouranakis M, Davlouros P, Hahalis G, Goudevenos J. Alexopoulos D, et al. J Thromb Haemost. 2016 Jun;14(6):1146-54. doi: 10.1111/jth.13316. Epub 2016 May 4. J Thromb Haemost. 2016. PMID: 26990959 Free article.

6

Ticagrelor, prasugrel, or clopidogrel in ST-segment elevation myocardial infarction: which one to choose?

Guimarães PO, Tricoci P. Guimarães PO, et al. Expert Opin Pharmacother. 2015;16(13):1983-95. doi: 10.1517/14656566.2015.1074180. Epub 2015 Jul 29. Expert Opin Pharmacother. 2015. PMID: 26224244 Review.

7

Antiplatelet Therapy in ACS Patients: Comparing Appropriate P2Y12 Inhibition by Clopidogrel to the Use of New P2Y12 Inhibitors.

Ristorto J, Messas N, Marchandot B, Kibler M, Hess S, Meyer N, Schaeffer M, Tuzin N, Ohlmann P, Jesel L, Morel O. Ristorto J, et al. J Atheroscler Thromb. 2018 Aug 1;25(8):674-689. doi: 10.5551/jat.40584. Epub 2018 Feb 8. J Atheroscler Thromb. 2018. PMID: 29415954 Free PMC article.

8

Physician and Hospital Utilization of P2Y12 Inhibitors in ST-Segment-Elevation Myocardial Infarction in the United States: A Study From the National Cardiovascular Data Registry's Research to Practice Initiative.

Faridi KF, Garratt KN, Kennedy KF, Maddox TM, Secemsky EA, Butala NM, Yeh RW. Faridi KF, et al. Circ Cardiovasc Qual Outcomes. 2020 Mar;13(3):e006275. doi: 10.1161/CIRCOUTCOMES.119.006275. Epub 2020 Mar 11. Circ Cardiovasc Qual Outcomes. 2020. PMID: 32156164

9

Contemporary Time Trends in Use of Antiplatelet Agents Among Patients with Acute Coronary Syndrome and Comorbid Diabetes Mellitus or Chronic Kidney Disease.

Desai RJ, Spoendlin J, Mogun H, Gagne JJ. Desai RJ, et al. Pharmacotherapy. 2017 Oct;37(10):1322-1327. doi: 10.1002/phar.2018. Epub 2017 Sep 19. Pharmacotherapy. 2017. PMID: 28833345

10

Contemporary Trends in Oral Antiplatelet Agent Use in Patients Treated with Percutaneous Coronary Intervention for Acute Coronary Syndrome.

Kim K, Lee TA, Touchette DR, DiDomenico RJ, Ardati AK, Walton SM. Kim K, et al. J Manag Care Spec Pharm. 2017 Jan;23(1):57-63. doi: 10.18553/jmcp.2017.23.1.57. J Manag Care Spec Pharm. 2017. PMID: 28025925 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

237 results

Results by year